Increase of Plasma IL-12/p40 Ratio Induced by the Combined Therapy of DNA Vaccine and Lamivudine Correlates with Sustained Viremia Control in CHB Carriers.

Immune Netw · 2009 · PMC2803296 · PMID 20107534

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

marginally significantp=0.09so close (0.05 < p ≤ 0.1)

VRs have significantly higher peak IL-12/p40 ratio than NVRs When the peak level of IL-12 was compared between VRs and NVRs, VRs showed approximately a 2-fold higher level of peak plasma IL-12 than NVRs, albeit this was marginally significant (218.0±41.4 vs. 108.1±28.6 pg/ml, respectively; AVR±SEM; p=0.09, Mann-Whitney U) ( Fig. 3A ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.